Cerebral Infarction

  1. Radicut (edaravone) — FDA approved under the brand name Radicava
    Radicut (edaravone) — FDA approved under the brand name Radicava
    by Mitsubishi Tanabe Pharma Co., Ltd.
    for Amyotrophic Lateral Sclerosis (ALS), Cerebral Infarction
    €992.00
  2. Edaravone (generic)
    Edaravone (generic)
    by Daiichi Sankyo Company Limited
    for Cerebral Infarction
    €391.00
View as Grid List

2 Items

per page
Set Descending Direction

Just one thing before you continue

Our service contains information about acquiring treatments that have been approved in another country. This includes professional information such as approval details, product information and pricing. By scrolling, you are declaring that you are requesting any such information.

No, take me out of here.
CONTINUE